Lexaria Bioscience (LEXX) announced the engagement of a ... These data will be presented at the 2024 San Antonio Breast Cancer Symposium.
News
- Lexaria Bioscience engages CRO for human pilot study of DehydraTEHC-liraglutide
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub ... - MarketScreener
These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. ... Biotechnology & Medical ...
- BioNTech makes case for VEGF bispecific in breast cancer patients with low PD-L1
The results, presented at the San Antonio Breast Cancer Symposium ... biotech?). 73.8% ORR. In its SABCS presentation, BioNTech shared data ...
- 'Revenge quitting' emerges as a worker trend for 2025 - MSN
'Revenge quitting' emerges as a worker trend for 2025. Story by SBG San Antonio Staff Reports ... biotechnology (down 7%), and media and communication ( ...
- Berkeley cuts red tape for R&D companies with new zoning - San Francisco Business Times
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech, research and development companies could soon find it ...